激励式肺量计减少创伤性肋骨骨折患者肺部并发症:随机对照试验
该随机对照试验纳入50例创伤性肋骨骨折成人患者,比较激励式肺量计治疗与对照组的肺功能和肺部并发症。结果显示对照组肺部并发症发生率显著更高(80.7% vs 29.2%,p=0.001),延迟性血胸也更常见(69.2% vs 29.2%,p=0.005),研究组FVC和FEV1改善更显著(p<0.001)。
要点
- 激励式肺量计可降低肋骨骨折患者肺部并发症发生率。
- 对照组延迟性血胸发生率显著高于研究组。
- 研究组肺功能指标FVC和FEV1改善更显著。
核心结论
- 使用激励式肺量计可减少肋骨骨折患者的肺部并发症并改善肺功能测试结果。
研究设计与样本
- 前瞻性随机对照试验,2014年6月至2017年5月纳入50例创伤性肋骨骨折成人患者,随机分为研究组(n=24)和对照组(n=26)。
主要发现
- 50例患者中28例(56%)发生肺部并发症,对照组发生率80.7%显著高于研究组29.2%(p=0.001)。
- 25例发生延迟性血胸,对照组69.2%显著高于研究组29.2%(p=0.005)。
- 对照组2例发生肺不张、1例发生气胸、5例需胸腔造口术。
- 肺功能测试显示对照组FVC和FEV1下降,研究组治疗前后FVC和FEV1改善显著更大(p<0.001)。
临床怎么用
- 激励式肺量计可作为肋骨骨折患者减少肺部并发症的成本效益良好的干预措施。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An incentive spirometer (IS) is a mechanical device that promotes lung expansion. It is commonly used to prevent postoperative lung atelectasis and decrease pulmonary complications after cardiac, lung, or abdominal surgery. This study explored its effect on lung function and pulmonary complication rates in patients with rib fractures. METHODS: Between June 2014 and May 2017, 50 adult patients with traumatic rib fractures were prospectively investigated. Patients who were unconscious, had a history of chronic obstructive pulmonary disease or asthma, or an Injury Severity Score (ISS) ≥ 16 were excluded. Patients were randomly divided into a study group (n = 24), who underwent IS therapy, and a control group (n = 26). All patients received the same analgesic protocol. Chest X-rays and pulmonary function tests (PFTs) were performed on the 5th and 7th days after trauma. RESULTS: The groups were considered demographically homogeneous. The mean age was 55.2 years and 68% were male. Mean pretreatment ISSs and mean number of ribs fractured were not significantly different (8.23 vs. 8.08 and 4 vs. 4, respectively). Of 50 patients, 28 (56%) developed pulmonary complications, which were more prevalent in the control group (80.7% vs. 29.2%; p = 0.001). Altogether, 25 patients had delayed hemothorax, which was more prevalent in the control group (69.2% vs. 29.2%; p = 0.005). Two patients in the control group developed atelectasis, one patient developed pneumothorax, and five patients required thoracostomy. PFT results showed decreased forced vital capacity (FVC) and forced expiratory volume in 1 s (FEV1) in the control group. Comparing pre- and posttreatment FVC and FEV1, the study group had significantly greater improvements (p < 0.001). CONCLUSIONS: In conclusion, the use of an IS reduced pulmonary complications and improved PFT results in patients with rib fractures. The IS is a cost-effective device for patients with rib fractures and its use has clinical benefits without harmful effects. TRIAL REGISTRATION: ClinicalTrials.gov, NCT04006587. Registered on 3 July 2019.
引用
- Sum SK, Peng YC, Yin SY, et al. Using an incentive spirometer reduces pulmonary complications in patients with traumatic rib fractures: a randomized controlled trial. Trials. 2019. PMID: 31888765. doi:10.1186/s13063-019-3943-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。